Understanding EUDAMED– Practical Guidance For Medical Device Firms

The EU’s Medical Device Regulation (MDR) continues to reshape regulatory compliance for device manufacturers. In 2026, the European Database on Medical Devices (EUDAMED) will add another layer of regulatory complexity with the goal of transforming transparency in the market.   

In this article, we demystify the database, outline what will be mandatory, and explain what medical device companies need to prepare ahead of 28th May 2026, when economic operator registration becomes compulsory.

What is EUDAMED?

EUDAMED is an acronym for the European Database on Medical Devices, introduced as part of the EU’s Medical Device Regulation (MDR). It will provide a single, unified source of information on medical devices, their safety records, and related clinical investigations.

The MDR tightened up compliance rules for medical devices intended for the EU market. Its impact is to improve patient safety by strengthening the accountability of legal manufacturers and improving the quality and visibility of clinical and technical evidence. EUDAMED plays a key role in making this happen. 

Under the previous legislation, the Medical Device Directive (MDD), information largely circulated within individual member states. Incident reports, safety concerns, and product listings were typically managed by the competent authority of the country where the manufacturer, or their authorized representative, was based. This frequently led to fragmented visibility across Europe. 

For example, a device marketed in Northern Europe could be introduced to other markets without local authorities having a clear understanding of its historical safety profile. EUDAMED solves this problem by enabling EU-wide transparency. For both authorities and industry, this shared data resource supports better monitoring, benchmarking, vigilance, and alignment with state-of-the-art expectations.

When do compliance rules for EUDAMED take effect?

EUDAMED is being released in modules, some of which are already operational for voluntary use. The European Commission has confirmed that registration of economic operators, including manufacturers, authorized representatives, and importers, will become mandatory from 28th May 2026. The key modules relevant to current and future obligations include:

Module 1: Actor Registration 

Companies must identify themselves within the system:

• EU-based manufacturers register directly
• Non-EU manufacturers register via their EU Authorized Representative
• Importers also require registration

Module 2: UDI And Device Registration 

Manufacturers must register their devices, complete with identifying information, UDI, intended purpose, and market placement data. While MDR-certified devices must be listed, this is not yet a requirement for legacy MDD devices unless there are safety issues. 

Module 3: Notified Bodies And Certificates 

Notified Bodies upload certificates directly into EUDAMED. This marks a major shift: certificates may no longer be emailed to manufacturers as standard. Certificates will also be publicly accessible, enhancing transparency on device risk class and conformity routes. In effect, the database becomes a single source of truth.

Module 4: Market Surveillance 

EUDAMED will also centralize reporting of serious incidents and field safety corrective actions. Once active, it will become an essential benchmark resource for manufacturers monitoring safety trends in comparable devices.

What are the new requirements for annual reviews?

Under the MDR, the Person Responsible for Regulatory Compliance (PRRC) must annually review and confirm the accuracy of EUDAMED data. 

Even if nothing had changed, the PRRC must actively reconfirm data within the system, and QMS procedures should explicitly describe how this review is carried out. 

It’s important to note that auditors have already begun issuing nonconformities where no procedure exists, so organizations should ensure this responsibility is fully integrated into their QMS.

What are the commercial benefits of EUDAMED?

Although manufacturers might see EUDAMED as an additional administrative burden, it could also be said to have strategic, commercial advantages. Here are three:

1. Benchmarking and competitive insight

Improved visibility can directly influence your regulatory strategy, especially in complex categories such as Software as a Medical Device (SaMD). EUDAMED enables you to:

• Compare intended purposes and risk classifications of similar devices
• Identify how competitors have justified their own product risk classes
• Evaluate state-of-the-art expectations when updating technical documents

2. Marketing and tender support

The vigilance module allows manufacturers to contrast their own safety record against competitors. For companies with strong post-market performance, this becomes a powerful differentiator in tenders or procurement discussions. It may soon be routine for procurement teams to consult EUDAMED to identify products with fewer incidents or field safety notices.

3. Transparency as a trust signal

Smaller or niche manufacturers may benefit from being early adopters of full EUDAMED transparency by showcasing MDR certification sooner, reinforcing credibility to customers and distributors.

Product portfolio strategy and regulatory compliance

EUDAMED is more than just a database. It’s a window into a manufacturer’s product portfolio. This creates both opportunities and sensitivities. For example, some larger organizations have been cautious about uploading extensive device lists, with good reason.

Publishing product portfolios can unintentionally reveal which products are likely to remain on the market over the next several years, and which may be discontinued due to insufficient clinical evidence or MDR challenges

EUDAMED also acts as a ledger of historical products, including those discontinued. Retired MDR devices appear with a strike-through but remain searchable, offering complete lifecycle visibility. This transparency means manufacturers must strategically manage:

• Which devices should transition to the MDR
• How to plan the timing of data uploads
• How to balance publicly available information with business decisions

The PRRC’s annual review adds another layer of compliance: device lists, certificates, market placement details, intended purpose descriptions, and company contact information must all remain accurate and aligned with product labelling and certificates.

When do you need external support with EUDAMED?

Uploading device data to EUDAMED is not always straightforward, especially for companies with extensive product ranges or complex configurations. Technical challenges include:

• Preparing XML files and bulk uploads: Large product lists must often be uploaded via structured XML files or automated machine-to-machine communication.
• Ensuring internal data matches EUDAMED fields: Detailed intended purpose statements, market placement per member state, device variants, PRRC identification, and unique device configurations all need correct formatting.
• Managing certificate access: Since Notified Bodies may stop sending certificates by email, companies must have clear internal procedures to retrieve and store them via EUDAMED.
• Listing system packs: System packs (such as first-aid kits containing multiple CE-marked components) may involve large numbers of device variants, each requiring proper identification and traceability.

Where can you find expert support with EUDAMED? 

EUDAMED is a core part of MDR compliance, commercial strategy, and future market access. With mandatory actor registration coming into force by 28 May 2026, and more modules becoming operational, now is the time for manufacturers to prepare.

Given these challenges, many companies find it essential to engage the support of external experts. Dawn Technology’s regulatory experts support organizations of all sizes with:

• Technical and regulatory interpretation of MDR requirements
• EUDAMED module completion
• PRRC compliance and annual review processes
• QMS procedure development
• Portfolio strategy and planning
• XML and bulk product upload assistance

If your organization needs support navigating EUDAMED or any other aspect of MDR compliance, contact Dawn Technology’s regulatory consultancy team today.

Our regulatory consultants support medical device manufacturers with EUDAMED registration, PRRC obligations, and MDR compliance planning. If you want to be ready for mandatory actor and (bulk) product registration in May 2026, get in touch to discuss a structured, audit-ready approach.